Edition:
United States

Orexo AB (ORX.ST)

ORX.ST on Stockholm Stock Exchange

30.35SEK
21 Jun 2018
Change (% chg)

-0.05kr (-0.16%)
Prev Close
30.40kr
Open
30.30kr
Day's High
30.45kr
Day's Low
29.80kr
Volume
37,443
Avg. Vol
61,243
52-wk High
52.75kr
52-wk Low
26.40kr

Chart for

About

Orexo AB is a Sweden-based company active within the pharmaceutical industry. It focuses primarily on the development of new, patented drugs by combining documented substances with technologies, and the new treatments for respiratory and inflammatory diseases. The Company has four commercialized products, several projects... (more)

Overall

Beta: 2.01
Market Cap(Mil.): kr1,050.64
Shares Outstanding(Mil.): 34.56
Dividend: --
Yield (%): --

Financials

  ORX.ST Industry Sector
P/E (TTM): 33.04 28.95 33.54
EPS (TTM): 0.92 -- --
ROI: 5.18 13.56 13.09
ROE: 11.13 15.37 15.10

BRIEF-Orexo Q1 EBIT Loss At SEK 21.8 Million

* Q1 NET REVENUES SEK 139.7 MILLION VERSUS SEK 127.4 MILLION YEAR AGO

Apr 26 2018

Earnings vs. Estimates